HRT Financial’s InMed Pharmaceuticals INM Stock Holding History

HRT Financial’s Portfolio INM Stock Details INM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,918	Closed	-$8K	–	2800
2024 Q3	$8K	Buy	1,918 +1,118	+140%	+$5.7K	﹤0.01%	2239
2024 Q2	$4K	Buy	+800	New	+$4.57K	﹤0.01%	2050

Other funds holding INM

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

HRT Financial's INM Position: Q4 2024 in Review

HRT Financial sold out of InMed Pharmaceuticals (INM) in Q4 2024, closing a stake of 1,918 shares — an estimated $8K sold.

HRT Financial first reported a position in INM in Q2 2024 and held it in 2 quarters. The position peaked at $8K in Q3 2024. 5 funds tracked by Wall St. Rank hold INM as of Q4 2024.

HRT Financial reported no remaining InMed Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
HRT Financial sold 1,918 InMed Pharmaceuticals shares in Q4 2024, an estimated $8K.
HRT Financial first reported a position in InMed Pharmaceuticals in Q2 2024 and held it in 2 quarters.
HRT Financial's InMed Pharmaceuticals position peaked at $8K in Q3 2024.
5 funds tracked by Wall St. Rank held InMed Pharmaceuticals as of Q4 2024.

Based on HRT Financial's 13F filing for Q4 2024, filed 14 Feb 2025.